Gene therapy firm Dimension would keep Cambridge office under latest buyout offer – Boston Business Journal
Boston Business Journal |
Gene therapy firm Dimension would keep Cambridge office under latest buyout offer
Boston Business Journal A bidding war between California-based Ultragenyx Pharmaceutical against Regenxbio of Maryland could determine the fate of Dimension's headquarters and employees. Subscribe to get the full story. Already a subscriber? Sign in. Subscribe to get the |
